Dow Up 0.36% Nasdaq Up 0.12%

Advaxis, Inc. (ADXS)

-NCM
3.15 Up 0.37(13.31%) 4:00PM EDT
Prev Close:2.78
Open:3.10
Bid:3.00 x 2100
Ask:3.37 x 100
1y Target Est:13.50
Beta:1.11
Next Earnings Date:N/A
Day's Range:3.00 - 3.42
52wk Range:2.46 - 11.70
Volume:1,230,377
Avg Vol (3m):146,862
Market Cap:60.71M
P/E (ttm):N/A
EPS (ttm):-2.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADXS

Comparison

Symbol% ChgMkt Cap
ADXSUp 13.31%60.71M
BVTI 0.00%N/A
DNDNDown 0.37%209.05M
VICLDown 0.79%110.76M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):53.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Oct-14) :-1.16
Quarterly EPS Est (Jul-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Advaxis, Inc., a clinical development stage biotechnology company, focuses on developing immunotherapies for cancer and infectious diseases. The company’s Lm -LLO immunotherapy platform technology stimulates the immune system to induce antige... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback